Aug 5, 2020   SOURCE: PR NewsWire

Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., Aug. 5, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic:

    --  The FDA issued its first warning letter to New Life International and
        its second warning letter to Fishman Chemical of North Carolina, LLC,
        both of which distribute chloroquine phosphate products intended to
        treat disease in aquarium fish. Chloroquine phosphate intended to treat
        disease in aquarium fish has not been approved, conditionally approved,
        or indexed. Although neither company identified in today's warning
        letters made claims about these products' use by people, the agency is
        concerned that consumers may mistake, and have mistaken, unapproved
        chloroquine phosphate animal drugs for the human drug chloroquine
        phosphate. People should not take any form of chloroquine unless it has
        been prescribed by a licensed health care provider.
    --  Testing updates:
        --  To date, the FDA has currently authorized 203 tests under EUAs;
            these include 166 molecular tests, 35 antibody tests, and 2 antigen
            tests.

Additional Resources:

    --  FAQs on Testing for SARS-CoV-2
    --  Policy for Coronavirus Disease-2019 Tests During the Public Health
        Emergency (Revised)
    --  Coronavirus Disease 2019 (COVID-19)

Media Contact: Lee.Herring@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

View original content to download multimedia:http://www.prnewswire.com/news-releases/coronavirus-covid-19-update-daily-roundup-301107144.html

SOURCE U.S. Food and Drug Administration